Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Salivary Gland Neoplasms 1Anatomic Stage I Breast Cancer AJCC v8 1Advanced Breast Carcinoma 1

Interventions

Practice Guidelines as Topic 8Standard of Care 7Specimen Handling 7Early Intervention, Educational 5pertuzumab 3Trastuzumab 3Methods 3Magnetic Resonance Spectroscopy 3Interviews as Topic 3Educational Status 3trastuzumab biosimilar HLX02 2Taxes 2Paclitaxel 2PF-05280014 2Ontruzant 2Ogivri 2Minoxidil 2Letrozole 2High-Energy Shock Waves 2Docetaxel 2Biopsy 2Acupuncture Therapy 22C4 antibody 2regadenoson 1pembrolizumab 1palbociclib 1nilotinib 1lorcaserin 1fisetin 1abemaciclib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Anatomic Stage I Breast Cancer AJCC v8 × CT-P6 × Clear all
NCT07407920 2026-02-12

Ph2 Study for Optimization of Adjunct Systemic Therapy in HER2+ Patients, MolecularPCR Trial

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
120 enrolled
Breast

Anatomic Stage I Breast Cancer AJCC v8

Data powered by HemOnc (CC BY 4.0) Colophon âš¡